share_log

Cardio Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Dogan Timur

Cardio Diagnostics | 4:持股变动声明-高管 Dogan Timur

SEC announcement ·  02/21 15:02
Moomoo AI 已提取核心信息
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Chief Technology Officer Timur Dogan. The transaction took place on January 23, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. The current number of shares held by Dogan after the transaction also remains undisclosed.
Cardio Diagnostics Holdings, Inc. (CDIO.US) has reported a transaction involving Chief Technology Officer Timur Dogan. The transaction took place on January 23, 2024. However, the specific details regarding the number of shares, nature of shares, transaction price, and the total value of shares involved in the transaction were not disclosed in the announcement. The current number of shares held by Dogan after the transaction also remains undisclosed.
Cardio Diagnostics Holdings, Inc.(CDIO.US)报告了一笔涉及首席技术官铁木尔·多安的交易。该交易于 2024 年 1 月 23 日进行。但是,公告中没有披露有关股票数量、股票性质、交易价格和交易所涉股票总价值的具体细节。交易后多安目前持有的股票数量也仍未公开。
Cardio Diagnostics Holdings, Inc.(CDIO.US)报告了一笔涉及首席技术官铁木尔·多安的交易。该交易于 2024 年 1 月 23 日进行。但是,公告中没有披露有关股票数量、股票性质、交易价格和交易所涉股票总价值的具体细节。交易后多安目前持有的股票数量也仍未公开。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息